ORIGINAL RESEARCH PAPER
The impact of the SARS-CoV-2 pandemic on screening tests rates in breast and cervical cancer
1
Gynaecology and Obstetrics Clinic, Clinical District Hospital No.1 , Rzeszow, Poland
Submission date: 2022-12-27
Acceptance date: 2023-04-17
Publication date: 2023-04-17
Corresponding author
Tomasz Zbigniew Zuzak
Gynaecology and Obstetrics Clinic, Clinical District Hospital No.1 , Rzeszow, Poland
Gynaecology and Obstetrics Clinic, Clinical District Hospital No.1 , Rzeszow, Poland
2023;1(1):1–9
KEYWORDS
TOPICS
ABSTRACT
The global SARS-CoV-2 pandemic had a significant impact on the availability of screening for breast and cervical cancer. In Poland, two pandemic waves were observed in 2020, characterized by an increase in the number of confirmed cases and deaths caused by the SARS-CoV-2 infection. This situation has reduced the number of patients registering for mammography and cytological tests. The aim of this study is to describe the problem using the available numerical data obtained from the database of the regional branch of the National Health Fund regarding the significant decrease in the number of screening tests for breast and cervical cancer in the Podkarpackie Voivodeship during the SARS-CoV-2 pandemic.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.